Strand Therapeutics
Daniel Gately has a background in microbiology and biotechnology, with experience in mRNA process development and manufacturing. Daniel has worked as a Scientist at Strand Therapeutics since December 2020 and held positions at bluebird bio and EMD Serono, Inc. with a focus on analytical methods for mRNA quality evaluation. Daniel also has experience in immunology research and laboratory analysis from internships at EMD Serono, Inc. and Analytical Testing Laboratory.
This person is not in any offices
Strand Therapeutics
3 followers
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics.